These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29465367)

  • 21. Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Chen JQ; Zilahi E; Papp G; Sipka S; Zeher M
    Int J Rheum Dis; 2017 May; 20(5):609-613. PubMed ID: 26620207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
    Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
    Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Salivary and serum beta 2-microglobulin in the diagnosis of primary Sjögren's syndrome].
    Bianucci G; Campana G; Bongi SM; Palermo C; D'Agata A
    Minerva Med; 1992 Nov; 83(11):705-13. PubMed ID: 1461541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren's Syndrome.
    Chen Y; Chen Y; Zu B; Liu J; Sun L; Ding C; Wang D; Cheng X; Yang D; Niu G
    J Immunol Res; 2020; 2020():9236234. PubMed ID: 33123604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
    Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
    PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome.
    Luo D; Chen Y; Zhou N; Li T; Wang H
    Mol Immunol; 2020 Nov; 127():107-111. PubMed ID: 32950755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum levels of high-mobility group box 1 (HMGB1) in primary Sjögren's syndrome.
    Dupire G; Nicaise C; Gangji V; Soyfoo MS
    Scand J Rheumatol; 2012 Mar; 41(2):120-3. PubMed ID: 22248244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
    Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cystatin C is not an appropriate marker for kidney involvement in patients with primary Sjögren's syndrome.
    Altunoğlu A; Erten Ş; Şahin A; Işıkoğlu S; Neşelioğlu S; Erzurum C; Erel Ö
    Int J Rheum Dis; 2017 Mar; 20(3):371-375. PubMed ID: 25367815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased frequency of CCR7
    Wu C; Yang P; Liu H; Xiao W; Zhao L
    Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
    Pertovaara M; Korpela M
    Rheumatology (Oxford); 2014 May; 53(5):927-31. PubMed ID: 24464708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA and mRNA expression profile of peripheral blood mononuclear cells in primary Sjögren's syndrome patients.
    Peng Y; Luo X; Chen Y; Peng L; Deng C; Fei Y; Zhang W; Zhao Y
    Sci Rep; 2020 Nov; 10(1):19629. PubMed ID: 33184486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
    Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
    Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
    Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
    Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase.
    Liu R; Su D; Zhou M; Feng X; Li X; Sun L
    Rheumatology (Oxford); 2015 Feb; 54(2):332-42. PubMed ID: 25169988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.